Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Volitionrx Ltd

NYSE: VNRX · Life Sciences · 7 alerts · CIK 93314

Share price
$0.1998Close, Nov 16
Market cap
$7.21M
Shares outstanding
36.08MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Volitionrx Ltd filings on SEC EDGAR ↗

8:31 AM ET 8-K
Executive Compensation

Volitionrx Executive Compensation

VolitionRx CEO Cameron Reynolds agreed to a further temporary reduction in his annual base salary from $355,456 to $236,970.50 as part of the company's cost-reduction measures. This follows a previous 25% reduction effective February 2026, bringing his total salary down from a contractual base of $473,941. The reduction will remain in effect until the Compensation Committee determines the company's financial stability is secured, potentially following a significant licensing or commercial agreement.

Term
temporary

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.